SCHEMBL22911018

SCHEMBL22911018

COCCOc1cc(C(=O)N2CC3C(C2)[C@@H]2CN(C(=O)c4ccc5[nH]nnc5c4)C[C@H]32)cc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 2/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ ROCK2 O75116 2/20 0.35
▸ RAB9A P51151 2/20 0.34
▸ FASN P49327 1/20 0.34
▸ MGLL Q99685 2/20 0.34
▸ LRRK2 Q5S007 2/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16759906 1.00 TTK (0.36) TTKPDK2ROCK2RAB9AFASN
SCHEMBL22911021 0.91 PDK2 (0.36) TTKPDK2ROCK2RAB9AFASN
SCHEMBL16759883 0.91 MGLL (0.42) MGLLHPGDKMT2AL3MBTL1NPC1
SCHEMBL22911145 0.91 MGLL (0.42) MGLLHPGDKMT2AL3MBTL1NPC1
SCHEMBL22910859 0.89 ROCK2 (0.42) TTKROCK2MGLLHPGDMEN1
SCHEMBL16759723 0.89 ROCK2 (0.42) TTKROCK2MGLLHPGDMEN1
SCHEMBL16759842 0.89 P2RY12 (0.39) PDK2ROCK2RAB9AMGLLHPGD
SCHEMBL22910814 0.89 P2RY12 (0.39) PDK2ROCK2RAB9AMGLLHPGD
SCHEMBL22910870 0.87 ATXN2 (0.42) ROCK2RAB9AMGLLPTGER4
SCHEMBL16759835 0.87 ATXN2 (0.42) ROCK2RAB9AMGLLPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2021-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL NPY1R, NPY2R, DECR1 TTK 4514/4885PDK2 984/4885ROCK2 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback